# Case Report: Simultaneous pancreas–kidney transplantation in MELAS: first reported case with 5-year follow-up

## TL;DR

A 40-year-old patient with MELAS received a successful simultaneous pancreas-kidney transplant, maintaining good function for 5 years.

## Contribution

This is the first reported case of successful simultaneous pancreas-kidney transplantation in a MELAS patient with long-term follow-up.

## Key findings

- The patient maintained excellent kidney function and insulin independence for 5 years post-transplant.
- No dialysis or exogenous insulin was needed during the 5-year follow-up period.
- Standard protocols with MELAS-specific adaptations were sufficient for successful transplantation.

## Abstract

Mitochondrial encephalomyopathy with lactic acidosis, and stroke-like episodes (MELAS) is a rare mitochondrial DNA disorder that, in severe cases, can result in insulin-dependent diabetes and end-stage renal disease (ESRD). While organ transplantation is a potential treatment, documented cases remain scarce.

A 40-year-old patient with dialysis-dependent ESRD and diabetes secondary to MELAS underwent simultaneous pancreas-kidney transplantation. The perioperative and postoperative periods were uncomplicated with only targeted MELAS-specific adaptations to standard protocols.

During the 5-year follow-up, the patient maintained excellent kidney allograft function and sustained insulin independence, with no need for dialysis or exogenous insulin therapy. At 5 years, creatinine was 77 µmol/L with an estimated GFR above 90 mL/min/1.73 m2, and glycated hemoglobin was 40 mmol/mol.

SPK transplantation may be feasible in carefully selected patients with MELAS, ESRD, and diabetes, providing durable renal and metabolic graft function at 5 years. To our knowledge, this is the first reported SPK case in MELAS, with extended follow-up.